After spending time with the Tampa Bay Buccaneers in the spring and summer, I came away thinking they would be a Super Bowl contender. Now I am convinced of it. The Bucs have navigated through a ...
An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...
Summit Therapeutics has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to show an improvement in overall survival in a lung cancer trial. New ...
The litany of big-ticket deals involving antibody-drug conjugates shows no sign of ending. In the latest recitation, Bristol-Myers Squibb is paying $800 million upfront for rights to a HER3-directed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback